The company was founded in 1999 by a group of experienced physicians and scientists. Their goal was to provide an effective, rapid and safe screening solution that accurately predicts early stage and asymptomatic pathologies of internal organs and systems, as well as diagnosing the acute and chronics ones.

Experts agree that an advanced and efficient screening technology with high predictive sensitivity follows an easier and much less complicated treatment administration, which consequently, it will reduce the hospital and outpatient costs.

Medex Test, Medex Screen’s flagship product, is a unique computer-based solution based on neuroreflexological and pathophysiological principles. It was designed for ambulatory care, private and public internal-medicine clinics, ER services, hospitals and occupational insurance companies, and for general screening of risk groups.

MedexTest is accurate, safe, affordable, cost effective, easy to use, non-invasive and radiation free. It is a highly effective mean of predicting the probability of disorders of the internal organs. It screens the cardiovascular, gastroenterological, hepatic, immune, respiratory, endocrine, genitourinary and spinal cord systems.

Extensive clinical trials approve that Medex Test is far more effective than traditional examination methods. It provides healthcare professionals with an additional examination tool that is a fast and economical diagnostic aid.

Medex Test is the first of several advanced screening devices which Medex Screen Ltd is developing.